Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Mar, 10 2026
Mar, 19 2026
Apr, 23 2026
Jan, 20 2026
Jan, 31 2026